Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future
(2018)118:74100.e11
This table shows how many weekly doses each vial size provides at standard tirzepatide titration doses
had a small sample size and only saw significant improvements following the initial 10 day intravenous treatment
Consult your provider before use if youve recently undergone facial treatments such as laser treatment or light therapy
US$ 23.95
/assets/images/provider/photos/2800172.png)
US$ 23.10
US$ 24.41
US$ 29.11
US$ 25.71
US$ 24.82
